Hypertension (blood pressure (BP) >140/90 mmHg) is a common comorbidity of type 2 DM (DM) and a major risk factor for macro- and microvascular complications. To review the effectiveness of different antihypertensive drugs in reducing BP, and diabetic complications in patients with DM, we analysed clinical trials, reviews and reports, published in Cochrane Library and PubMed from 1991 to 2004. Evidences suggest that optimal control of hypertension complications is obtained in diabetic patients when BP values are <130/80 mmHg. Different drug classes result useful to obtain this target BP, but their effects on different metabolic and non-metabolic aspects have to be taken in account and a flexible approach according to individual response to different regimens is essential.

Recommendations for the Treatment of Hypertension in Patients with DM: Critical Evaluation Based on Clinical Trials / Derosa G.; Salvadeo S.; Cicero A. - In: CURRENT CLINICAL PHARMACOLOGY. - ISSN 1574-8847. - STAMPA. - 1:1(2006), pp. 21-33. [10.2174/157488406775268237]

Recommendations for the Treatment of Hypertension in Patients with DM: Critical Evaluation Based on Clinical Trials.

CICERO, ARRIGO FRANCESCO GIUSEPPE
2006

Abstract

Hypertension (blood pressure (BP) >140/90 mmHg) is a common comorbidity of type 2 DM (DM) and a major risk factor for macro- and microvascular complications. To review the effectiveness of different antihypertensive drugs in reducing BP, and diabetic complications in patients with DM, we analysed clinical trials, reviews and reports, published in Cochrane Library and PubMed from 1991 to 2004. Evidences suggest that optimal control of hypertension complications is obtained in diabetic patients when BP values are <130/80 mmHg. Different drug classes result useful to obtain this target BP, but their effects on different metabolic and non-metabolic aspects have to be taken in account and a flexible approach according to individual response to different regimens is essential.
2006
Recommendations for the Treatment of Hypertension in Patients with DM: Critical Evaluation Based on Clinical Trials / Derosa G.; Salvadeo S.; Cicero A. - In: CURRENT CLINICAL PHARMACOLOGY. - ISSN 1574-8847. - STAMPA. - 1:1(2006), pp. 21-33. [10.2174/157488406775268237]
Derosa G.; Salvadeo S.; Cicero A
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/35689
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 6
  • ???jsp.display-item.citation.isi??? ND
social impact